## ALGN: Align Technology, Inc. - XLV: Healthcare

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.6% in mid entry zone (3.0-6.0%), top quartile (87th pct) cross-sectional ranking. Short-term MRS_5 (3.2%) confirms momentum alignment. Strong momentum (+2.0% 5-day acceleration). Outperforming sector by 6.1%. Caution: overbought RSI (73).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($146.92)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. Is Align Technology (ALGN) Quietly Recasting Its Moat Around AI-Driven End-to-End Dental Workflows?**
- Source: Simply Wall Street | 20251204T200756 | Somewhat-Bullish | Relevance: 100%
- Align Technology (ALGN) is enhancing its digital dentistry platform with AI-driven tools, faster scanners like the iTero Lumina, and integrated software to create end-to-end dental workflows. This strategic push aims to deepen digital workflow adoption, although the company faces challenges with softer case starts and pricing pressure. The article suggests this technological advancement could influence Align's investment narrative, with analysts projecting significant revenue and earnings growth by 2028.

**2. Align Technology Showcases Digital Dentistry Innovations at Greater New York Dental Meeting 2025**
- Source: Business Wire | 20251204T090919 | Bullish | Relevance: 100%
- Align Technology highlighted its latest innovations in digital dentistry at the Greater New York Dental Meeting 2025, showcasing advancements across its Align™ Digital Platform. Key features included the iTero Lumina™ scanner, Align™ Oral Health Suite, Invisalign Smile Architect™, iTero™ Design Suite, and ClinCheck® Signature experience, alongside educational sessions from industry experts. The company emphasized how these innovations enhance treatment planning, practice workflows, and patient experiences for dental professionals.

**3. Align Technology (NASDAQ: ALGN) spotlights iTero, exocad, Invisalign at GNYDM 2025**
- Source: Stock Titan | 20251203T205500 | Bullish | Relevance: 100%
- Align Technology showcased its latest digital dentistry innovations at the Greater New York Dental Meeting (GNYDM) 2025, highlighting advancements across its Align Digital Platform, including the Invisalign system, iTero intraoral scanners, and exocad CAD/CAM software. The company featured new products like the iTero Lumina scanner and Invisalign Smile Architect, alongside educational sessions for dental professionals. These innovations aim to enhance treatment planning, practice efficiency, and patient outcomes for dental practices worldwide.

**4. Align Showcases Digital Advancements at GNYDM 2025**
- Source: Dentistry Today | 20251204T154751 | Bullish | Relevance: 100%
- Align Technology showcased its latest innovations in digital dentistry at the Greater New York Dental Meeting (GNYDM) 2025, highlighting advancements across its Align Digital Platform, including the iTero Lumina scanner, Align Oral Health Suite, and Invisalign Smile Architect. The company and its subsidiary exocad also hosted educational sessions and provided hands-on experiences with their technology. These offerings aim to enhance clinical outcomes, patient treatment experiences, and practice growth for dental professionals.

**5. Align Technology Inc. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251203T171800 | Bullish | Relevance: 100%
- Align Technology Inc. (ALGN) saw its stock advance by 2.70% to $155.00 on Wednesday. This strong performance occurred during a favorable trading session where the S&P 500 Index and Dow Jones Industrial Average also rose. This marks the second consecutive day of gains for Align Technology Inc.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.6% (+0.7%)
- Blackrock Inc.: 6.9% (-3.4%)
- Ninety One UK Ltd: 6.3% (+136.6%)
- Capital Internationa: 4.2% (+88.6%)
- State Street Corpora: 4.0% (-1.3%)

### Key Risks

1. High beta (1.86) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +2.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.95 indicates undervaluation relative to growth. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.5B |
| Beta | 1.86 |
| 52W Range | $122.00 - $237.23 |
| Short Interest | 5.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.95 |
| Forward P/E | 14.3 |
| Current P/E | 15.4 |
| YoY Growth | 7.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 2.6% to 4.6% (+2.0% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 87th percentile. MRS_5 at 3.2% confirms short-term momentum alignment. Outperforming sector by 6.1pp, stock-specific strength. Below SMA200 (0.98x), long-term trend not supportive. MACD histogram positive (1.70), confirming momentum. RSI overbought at 73, risk of mean reversion. OFD pattern: +MLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.63% (CS: 88) | Strong |
| RSI_14 | 73.0 | Overbought |
| MACD Histogram | 1.70 | Bullish |
| vs SMA20 | 1.105x | Above |
| vs SMA50 | 1.154x | Above |
| vs SMA200 | 0.977x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $156.84
- **Stop Loss:** $146.92 (6.3% risk)
- **Target:** $171.72 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 50
- **Position Value:** $7,842.00
- **Portfolio %:** 7.84%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-02-04 (Est: $2.96)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.41 | $2.61 | +8.4% |
| 2025Q2 | $2.57 | $2.49 | -3.3% |
| 2025Q1 | $1.99 | $2.13 | +7.1% |
| 2024Q4 | $2.45 | $2.44 | -0.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*